(12) United States Patent (10) Patent No.: US 9.273,100 B2 Hallen-Adams Et Al
Total Page:16
File Type:pdf, Size:1020Kb
US009273 100B2 (12) United States Patent (10) Patent No.: US 9.273,100 B2 Hallen-Adams et al. (45) Date of Patent: Mar. 1, 2016 (54) USE OF GALERINA MARGINATA GENES AND “U.S. Appl. No. 12/268,229, Final Office Action mailed Feb. 28, PROTEINS FOR PEPTIDE PRODUCTION 2013', 7 pgs. “U.S. Appl. No. 12/268,229. Final Office Action mailed Apr. 4. 2012”, 8 pgs. (75) Inventors: Heather E. Hallen-Adams, Lincoln, NE “U.S. Appl. No. 12/268,229. Non Final Office Action mailed Jul 16, (US); John S. Scott-Craig, East 2012', 9 pgs. Lansing, MI (US); Jonathan D. Walton, “U.S. Appl. No. 12/268,229. Non Final Office Action mailed Jul 22, East Lansing, MI (US); Hong Luo, 2011”, 13 pgs. Lansing, MI (US) “U.S. Appl. No. 12/268,229. Non Final Office Action mailed Dec. 21, 2010”, 13 pgs. (73) Assignee: Board of Trustees of Michigan State “U.S. Appl. No. 12/268,229. Preliminary Amendment filed Jun. 10, University, East Lansing, MI (US) 2009, 16 pgs. “U.S. Appl. No. 12/268,229, Response filed May 24, 2013 to Final Office Action mailed Feb. 28, 2013”, 6 pgs. (*) Notice: Subject to any disclaimer, the term of this “U.S. Appl. No. 12/268,229. Response filed May 27, 2011 to Supple patent is extended or adjusted under 35 mental Non-Final Office Action mailed Dec. 27, 2010”, 31 pgs. U.S.C. 154(b) by 105 days. “U.S. Appl. No. 12/268,229. Response filed Jun. 4, 2012 to Final Office Action mailed Apr. 4, 2012, 13 pgs. (21) Appl. No.: 13/362,561 “U.S. Appl. No. 12/268,229, Response filed Jun. 25, 2012 to Advi sory Action mailed Jun. 13, 2012 and to Final Office Action mailed (22) Filed: Jan. 31, 2012 Apr. 4, 2012, 15 pgs. “U.S. Appl. No. 12/268,229, Response filed Oct. 18, 2010 to Restric (65) Prior Publication Data tion Requirement mailed Sep. 16, 2010”. 1 pg. “U.S. Appl. No. 12/268,229, Response filed Nov. 16, 2012 to Non US 2012/O276588A1 Nov. 1, 2012 Final Office Action mailed Jul. 16, 2012', 12 pgs. “U.S. Appl. No. 12/268,229, Response filed Dec. 22, 2011 to Non Related U.S. Application Data Final Office Action mailed Jul. 22, 2011”, 13 pgs. “U.S. Appl. No. 12/268,229. Restriction Requirement mailed Sep. (63) Continuation-in-part of application No. 12/268,229. 16, 2010”, 7 pgs. filed on Nov. 10, 2008. “U.S. Appl. No. 12/268,229, Supplemental Non Final Office Action mailed Dec. 27, 2010”, 14pgs. (60) Provisional application No. 61/002,650, filed on Nov. “Machine Translation of CN1341362, obtained on Dec. 21, 2010’, 7 9, 2007. OgS. Ahn, J. H., et al., “An Extended Physical Map of the TOX2 Locus of (51) Int. Cl. Cochliobolus carbonum Required for Biosynthesis of HC-Toxin'. CI2N 9/48 (2006.01) Fungal Genet. Biol. 35(1), (2002), 31-38. CI2N L/20 (2006.01) Alves, A.M. C. R. et al., “Highly Efficient Production of Laccase by CI2O I/68 (2006.01) the Basidiomycete Pycnoportis cinnabarintis',s Appl. Environ. C07K L/00 (2006.01) Microbiol., 70(11). (2004), 6379-6384. C07K 7/64 (2006.01) Bamburg, J. R., “Proteins of the ADF/cofilin family: essential regu lators of actin dynamics.”. Annu. Rev. Cell. Dev. Biol. 15, (1999), C07K I4/375 (2006.01) 185-230. (52) U.S. Cl. Benedict, R. G., et al., "Fermentative Production of Amanita Toxins CPC ................. C07K 7/64 (2013.01); C07K 14/375 by a Strain of Galerina marginata", J. Bacteriol. 91(3), (1966), (2013.01) 1380-1381. (58) Field of Classification Search Beutler, J. A., et al., "Chemical Variation in Amanita', J. Nat. Prod, USPC .................. 536/23.2; 435/6, 212, 6.1, 252.31 44(4), (1981), 422-431. See application file for complete search history. Brandt, I., et al., “Suggested functions for prolyl oligopeptidase: A puzzling paradox”. Clin. Chim Acta, 377(1-2), (2007), 50-61. (56) References Cited (Continued) U.S. PATENT DOCUMENTS Primary Examiner — Maryam Monshipouri 4,683, 195 A 7, 1987 Mullis et al. (74) Attorney, Agent, or Firm — Schwegman Lundberg & 4,683.202 A 7, 1987 Mullis Woessner, P.A. 4,965,188 A 10, 1990 Mullis et al. 5,928,906 A 7, 1999 Koster et al. (57) ABSTRACT 2001 OO14445 A1 8, 2001 Urnovitz 2004/0081978 A1 4/2004 Ziman et al. The present invention relates to compositions and methods 2005/0255486 A1 11/2005 Behlke et al. comprising genes and peptides associated with cyclic pep 2006/0141495 A1 6, 2006 Wu 2008/0076677 A1 3/2008 Yershov et al. tides and cyclic peptide production in mushrooms. In particu 2009/0093620 A1 4/2009 Kovalic et al. lar, the present invention relates to using genes and proteins 2010/0267,019 A1 10/2010 Hallen et al. from Galerina species encoding peptides specifically relating to amatoxins in addition to proteins involved with processing FOREIGN PATENT DOCUMENTS cyclic peptide toxins. In a preferred embodiment, the present invention also relates to methods for making Small peptides CN 1341362 A 3, 2002 and Small cyclic peptides including peptides similar to aman OTHER PUBLICATIONS itin. Further, the present inventions relate to providing kits for making Small peptides. “U.S. Appl. No. 12/268,229, Advisory Action mailed Jun. 13, 2012”. 3 pgs. 16 Claims, 79 Drawing Sheets US 9.273,100 B2 Page 2 (56) References Cited Letschert, K., et al., “Molecular Characterization and Inhibition of Amanitin Uptake into Human Hepatocytes.”. Toxicol Sci., 91(1), OTHER PUBLICATIONS (2006), 140-149. Bulaj. G. et al., “Efficient oxidative folding of conotoxins and the Lindell, T.J., et al., “Specific Inhibition of Nuclear RNA Polymerase radiation of venomous cone snails'. Proc. Natl. Acad. Sci. USA, 100 II by O-Amanitin”, Science, 170(3959), (1970), 447-449. Lugones, L. G., et al., “Introns are necessary for mRNA accumula 2), (2003), 14562-14568. tion in Schizophyilurn commune', Mol. Microbiol. 32(4), (1999), Bushnell, D.A., et al., “Structural basis of transcription: O-Amanitin 681-700. RNA polymerase II cocrystal at 2.8 A resolution”, Proc. Natl. Acad. Malonek, S., et al., “Functional Characterization of Two Cytochrome Sci. USA,99(3), (2002), 1218-1222. P450 Monooxygenase Genes, P450-1 and P450-4, of the Gibberellic Butera, R., et al., “Diagnostic accuracy of urinary amanitin in Sus acid Gene Cluster in Fusarium proliferatum (Gibberellafiujikuroi pected mushroom poisoning: a pilot study’. Clinical Toxicology, MP-D)”, Appl. Environ. Microbiol. 71(3), (2005), 1462-1472. 42(6). (2004), 901-912. Maniatis, T., et al., “Regulation of Inducible and Tissue-Specific Craik. D. J., “Chemistry. Seamless Proteins Tie Up Their Loose Gene Expression”, Science, 236(4806), (1987), 1237-1245. Ends', Science, 311(5767), (2006), 1563-1564. Marqulies, M., et al., “Genome Sequencing in Microfabricated High Craik. D. J., et al., “The chemistry and biology of cyclotides'. Curr: Density Picolitre Reactors', Nature, 437(7057), (2005), 376-380. Opin. Drug Discov. Devel., 10(2), (2007), 176-184. May, J. P. et al., “Tryptathionine Bridges in Peptide Synthesis'. Crooks, G. E., et al., “WebLogo: A Sequence Logo Generator'. Biopolymers, 88(5), (2007), 714-724. Genome Res, 4(6), (2004), 1188-1190. Muraoka, S., et al., “Detection and Identification of Amanitins in the Cunningham, D. F., et al., “Proline specific peptidases”. Biochim Wood-Rotting Fungi Galerina fasciculata and Galerina Biophy's Acta, 1343(2), (1997), 160-186. helvoliceps, Appl. Environ. Microbiol. 65(9), (1999), 4207-4210. Duquesne, S., et al., “Two Enzymes Catalyze the Maturation of a Muraoka, S., et al., “Effective Production of Amanitins by Two-Step Lasso Peptide in Escherichia coli'', Chem. Biol., 14(7), (2007), 793 Cultivation of the Basidiomycete, Galerina fasciculata GF-060". J. 803. Biosci. Bioeng, 89(1), (2000), 73-76. Nikolskaya, A. N., et al., “Identification of peptide synthetase-encod Enjalbert. F., et al., “Treatment of Amatoxin Poisoning: 20-Year ing genes from filamentous fungi producing host-selective Retrospective Analysis, review of poisonings.”. J. Toxicol. Clin. phytotoxins or analogs”. Gene, 165(2), (1995), 207-211. Toxicol., 40(6), (2002), 715-757. Novick, R. P. et al., “Quorum Sensing in Staphylococci'. Annu. Rev. Escoubas, P. “Molecular diversification in spider venoms: A web of Genet., 42, (2008), 541-564. combinatorial peptide libraries.”. Mol. Divers., 10(4), (2006), 545 Olivera, B. M.. “Conus Peptides: Biodiversity-based Discovery and 554. Exogenomics”. J. Biol. Chern., 281, (2006), 31173-3 1177. Finking, R. et al., “Biosynthesis of Nonribosomal Peptides'. Annu. Panaccione, D. G., “Multiple families of peptide synthetase genes Rev. Microbiol. 58, (2004), 453-488 from ergopeptine-producing fungi'. Mycological Research, 100(4), Frohman, M. A., et al., “Rapid Production of Full-Length cDNAs (1996), 429-436. from Rare Transcripts: Amplification Using a Single Gene-Specific Panaro. F., et al., “Liver transplantation represents the optimal treat Oligonucleotide Primer'. Proc. Natl. Acad. Sci. USA, 85(23), ment for fulminant hepatic failure from Amanita phalloides poison (1988), 8998-9002. ing”. Transplant International, 19(4), (2006), 344-345. Garcia-Horsman, J. A., et al., “Deficient activity of mammalian Polgár, L., “The prolyl oligopeptidase family”. Cell. Mol. Life Sci., prolyl oligopeptidase on the immunoactive peptide digestion in 59(2), (2002), 349-362. coeliac disease'. Scand. J. Gastroenterol. 42(5), (2007), 562-571. Richter, K., et al., “cDNAs encoding D-Aladeltorphin precursors Gardiner, D. M., et al., “The sirodesmin biosynthetic gene cluster from skin of Phyliomedusa bicolor also contain genetic information ofthe plant pathogenic fungus Leptosphaeria maculans', Mol. for three dermorphin-related opioid peptides'. Proc. Nat. Acad. Sci. Microbiol. 53(5), (2004), 1307-1318. USA, 87(10), (1990), 4836-4839.